Zhenjiang Zhao

2.3k total citations
93 papers, 1.5k citations indexed

About

Zhenjiang Zhao is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Zhenjiang Zhao has authored 93 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 24 papers in Oncology and 17 papers in Organic Chemistry. Recurrent topics in Zhenjiang Zhao's work include Biochemical and Molecular Research (10 papers), Cancer therapeutics and mechanisms (9 papers) and Melanoma and MAPK Pathways (8 papers). Zhenjiang Zhao is often cited by papers focused on Biochemical and Molecular Research (10 papers), Cancer therapeutics and mechanisms (9 papers) and Melanoma and MAPK Pathways (8 papers). Zhenjiang Zhao collaborates with scholars based in China, United States and Norway. Zhenjiang Zhao's co-authors include Yufang Xu, Honglin Li, Xuhong Qian, Guoguo Jin, Zhiping Guo, Jin Huang, Yinghui Ge, Jian‐Jiang Zhong, Li Zhu and Xiaofeng Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.

In The Last Decade

Zhenjiang Zhao

85 papers receiving 1.5k citations

Peers

Zhenjiang Zhao
Nan Ma China
Tina S. Homayouni Canada
Mohane Selvaraj Coumar India
Weidong Zhang China
Xiangqian Kong China
Raafat El‐Awady United Arab Emirates
Yanmin Zhang China
Fatemeh Mosaffa Iran
Qiu Sun China
Nan Ma China
Zhenjiang Zhao
Citations per year, relative to Zhenjiang Zhao Zhenjiang Zhao (= 1×) peers Nan Ma

Countries citing papers authored by Zhenjiang Zhao

Since Specialization
Citations

This map shows the geographic impact of Zhenjiang Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenjiang Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenjiang Zhao more than expected).

Fields of papers citing papers by Zhenjiang Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenjiang Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenjiang Zhao. The network helps show where Zhenjiang Zhao may publish in the future.

Co-authorship network of co-authors of Zhenjiang Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenjiang Zhao. A scholar is included among the top collaborators of Zhenjiang Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenjiang Zhao. Zhenjiang Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Chao, Mei Yu, Zhong Yang, et al.. (2025). Effect and mechanism of Li content on the corrosion resistance of Al-Li alloy. Corrosion Science. 246. 112768–112768. 3 indexed citations
2.
Chen, Ziqi, Siyu Wang, Jie Wang, et al.. (2025). Discovery of a Proteolysis-Targeting Chimera Degrader of JAK2 as a Potential Therapeutic Agent for JAK2-Mediated Myeloproliferative Neoplasms. Journal of Medicinal Chemistry. 68(11). 12085–12099. 1 indexed citations
3.
Ye, Tian-Yu, Zhongping Xu, Shanshan Guo, et al.. (2025). Discovery and SAR study of highly selective and potent 1,2,4-oxadiazole-based S1PR1 agonists. European Journal of Medicinal Chemistry. 300. 118097–118097.
4.
Xu, Wenyue, et al.. (2024). Design, synthesis and structure-activity relationship of malonic acid non-nucleoside derivatives as potent CD73 inhibitors. Bioorganic & Medicinal Chemistry Letters. 112. 129946–129946.
5.
Xu, Wenyue, Chen Zhang, Zedong Wang, et al.. (2024). Discovery of Novel Non-Nucleoside Inhibitors Interacting with Dizinc Ions of CD73. Journal of Medicinal Chemistry. 67(11). 9686–9708. 4 indexed citations
6.
Li, Shiliang, Weijia Sun, Lili Zhu, et al.. (2024). Tamsulosin ameliorates bone loss by inhibiting the release of Cl − through wedging into an allosteric site of TMEM16A. Proceedings of the National Academy of Sciences. 122(1). e2407493121–e2407493121. 1 indexed citations
7.
Xie, Lijuan, Xiaodong Zhang, Fengzhi Wang, et al.. (2023). Design, synthesis and biological evaluation of fluorescent derivatives of ursolic acid in living cells. Chinese Chemical Letters. 35(5). 108825–108825.
8.
Diao, Yanyan, Dandan Liu, Huan Ge, et al.. (2023). Macrocyclization of linear molecules by deep learning to facilitate macrocyclic drug candidates discovery. Nature Communications. 14(1). 25–42. 24 indexed citations
9.
Ge, Huan, Yanyan Diao, Wanqi Wang, et al.. (2022). Efficacy of WWQ-131, a highly selective JAK2 inhibitor, in mouse models of myeloproliferative neoplasms. Biomedicine & Pharmacotherapy. 156. 113884–113884. 5 indexed citations
10.
He, Huan, Mengting Zhang, Haiqin Zhang, et al.. (2022). Design, Synthesis and Biological Evaluation of Potent and Selective S1PR1 Agonists for the Treatment of Ulcerative Colitis. Chinese Journal of Chemistry. 40(22). 2625–2632. 6 indexed citations
11.
Sun, Hongxia, Lu Li, Lili Zhu, et al.. (2021). Design, Synthesis, and Structure–Activity Relationship Study of Potent MAPK11 Inhibitors. Molecules. 27(1). 203–203. 4 indexed citations
12.
Yuan, Yuan, Lei Jiang, Yuanyuan Ge, et al.. (2021). Discovery, Optimization, and Structure–Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma. Journal of Medicinal Chemistry. 64(18). 13572–13587. 5 indexed citations
13.
Yang, Tingyuan, Jie Wang, Mengzhen Lai, et al.. (2020). Design, synthesis and biological evaluation of potent EGFR kinase inhibitors against 19D/T790M/C797S mutation. Bioorganic & Medicinal Chemistry Letters. 30(16). 127327–127327. 23 indexed citations
14.
Zhang, Tao, Shiliang Li, Linjiang Tong, et al.. (2019). Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFRL858R/T790M/C797S. ACS Medicinal Chemistry Letters. 10(6). 869–873. 52 indexed citations
15.
Li, Shiliang, Shichao Cui, Jiawei Wang, et al.. (2019). Discovery of a Natural-Product-Derived Preclinical Candidate for Once-Weekly Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 62(5). 2348–2361. 24 indexed citations
16.
Xu, Minghao, Junsheng Zhu, Yanyan Diao, et al.. (2013). Novel Selective and Potent Inhibitors of Malaria Parasite Dihydroorotate Dehydrogenase: Discovery and Optimization of Dihydrothiophenone Derivatives. Journal of Medicinal Chemistry. 56(20). 7911–7924. 48 indexed citations
17.
Gao, Rui, Sha Liao, Chen Zhang, et al.. (2013). Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship. European Journal of Medicinal Chemistry. 62. 597–604. 8 indexed citations
18.
Qian, Zhi‐Gang, Zhenjiang Zhao, Yufang Xu, Xuhong Qian, & Jian‐Jiang Zhong. (2005). Novel synthetic 2,6-dichloroisonicotinate derivatives as effective elicitors for inducing the biosynthesis of plant secondary metabolites. Applied Microbiology and Biotechnology. 71(2). 164–167. 12 indexed citations
19.
Wang, Wei, Zhenjiang Zhao, Yufang Xu, Xuhong Qian, & Jian‐Jiang Zhong. (2005). Efficient induction of ginsenoside biosynthesis and alteration of ginsenoside heterogeneity in cell cultures of Panax notoginseng by using chemically synthesized 2-hydroxyethyl jasmonate. Applied Microbiology and Biotechnology. 70(3). 298–307. 44 indexed citations
20.
Zhao, Zhenjiang, et al.. (2004). Novel synthetic jasmonates as highly efficient elicitors for taxoid production by suspension cultures of Taxus chinensis. Biotechnology and Bioengineering. 86(5). 595–599. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nan Ma Breakdown of academic impact, for papers by Tina S. Homayouni Breakdown of academic impact, for papers by Mohane Selvaraj Coumar Breakdown of academic impact, for papers by Weidong Zhang Breakdown of academic impact, for papers by Xiangqian Kong Breakdown of academic impact, for papers by Raafat El‐Awady Breakdown of academic impact, for papers by Yanmin Zhang Breakdown of academic impact, for papers by Fatemeh Mosaffa Breakdown of academic impact, for papers by Qiu Sun
Rankless by CCL
2026